An assessment of the antidepressant potential of deramciclane in two animal tests
2025-12-09
(Press-News.org) Background and objectives
Preclinical studies of the serotonin 2A (5-HT2A) antagonist deramciclane suggested an anxiolytic profile, which has not been unequivocally established in the clinic. The same receptor profile also indicated that the compound may exhibit antidepressant potential. However, evidence for these effects remains inconclusive. The present study examined the effect of the drug in two preclinical tests with predictive validity for antidepressant activity.
Methods
The antidepressant-like activity of deramciclane was assessed in male Sprague-Dawley rats by measuring immobility time in the forced swim test (doses: 1, 5 mg/kg) and ambulation scores in the bilateral olfactory bulbectomized (doses: 5, 10 mg/kg) rat model. In both tests, the clinically effective antidepressant imipramine served as the control condition.
Results
In the forced swim test, there was a statistically significant effect of treatment on immobility time (F2,34 = 5.77; p < 0.01; analysis of variance), which was attributable to the effect of the 5 mg/kg dose (p < 0.01; Bonferroni post-hoc test). Deramciclane at 1 mg/kg was not significantly different from vehicle-treated animals. By contrast, neither dose of deramciclane (5 mg/kg or 10 mg/kg) reversed the hyperactivity of olfactory bulbectomized rats, whereas imipramine was active in both tests.
Conclusions
Deramciclane demonstrates contradictory evidence for antidepressant-like activity in two validated pharmacological tools that identify such potential. The agent is clearly active in the forced swim test but not in the bulbectomized rat model. Further evaluation of the antidepressant-like potential of deramciclane in pharmacological models with predictive validity is warranted, and a more detailed examination of the dose-response relationship may be informative.
Full text
https://xiahepublishing.com/2572-5505/JERP-2025-00033
The study was recently published in the Journal of Exploratory Research in Pharmacology.
Journal of Exploratory Research in Pharmacology (JERP) publishes original innovative exploratory research articles, state-of-the-art reviews, editorials, short communications that focus on novel findings and the most recent advances in basic and clinical pharmacology, covering topics from drug research, drug development, clinical trials and application.
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-12-09
PITTSBURGH, – Researchers at the University of Pittsburgh and UPMC Children’s Hospital of Pittsburgh discovered a promising new biomarker of “complicated” mild- to severe-pediatric traumatic brain injury, or TBI. Unlike a concussion—which usually resolves within weeks—complicated TBI requires at least an overnight hospital stay, signaling a more serious injury.
Published today in the Journal of Neurotrauma, this study is first to identify a signature of potentially ...
2025-12-09
McGill University researchers have identified a brain function that helps explain why childhood stress raises metabolic health risks for some women later in life.
A new study found that variations in the brain’s insulin receptor network affect how women respond to early-life adversity. This effect has a lesser impact in men, suggesting there is a sex-specific process at play.
The findings, published in Communications Biology (Nature Portfolio), point to the brain’s insulin receptor network as a promising avenue for earlier detection and future prevention strategies for metabolic syndrome, a major driver of cardiovascular ...
2025-12-09
SAN ANTONIO — December 9, 2025 — A new study led by Southwest Research Institute (SwRI) links quasi-periodic pulsations (QPPs) in solar flares to dynamic oscillations in magnetic reconnection, a phenomenon that can drive space weather and affect technology on Earth. This research could help refine traditional solar flare models and provide new insights into the mechanisms driving them.
Magnetic reconnection occurs when magnetic field lines in plasma break and reconnect, releasing immense energy into the surrounding atmosphere ...
2025-12-09
New York, NY —The American Federation for Aging Research (AFAR) and Hevolution Foundation are pleased to announce the third cohort of the Hevolution/AFAR New Investigator Awardees in Aging Biology and Geroscience Research. This grant program enables junior investigators with labs in the US and Canada, and with at least three years of independent research, to advance research projects in basic biology of aging, as well as geroscience projects that translate advances in basic research on aging biology from the laboratory to the clinic, paving ...
2025-12-09
FOR IMMEDIATE RELEASE
EMBARGOED UNTIL DECEMBER 9, 2025
GeoFlame VISION: Using AI and Satellite Imagery to Predict Future Wildfire Risk
A new computer model produces a dynamic wildfire risk map,
starting with the state of California
Washington, D.C., December 9, 2025 – Wildfires pose a significant threat across the southwestern United States, due to the region’s unique topography and weather conditions. Accurately identifying locations at the highest risk of a severe wildfire is critical ...
2025-12-09
FOR IMMEDIATE RELEASE
EMBARGOED UNTIL DECEMBER 9, 2025
Nationwide Study Suggests that Water Treatment Methods May Impact the Risk of Legionnaires’ Disease
Higher rates of disease are seen in zip codes served by water treatment plants that use chlorine as the primary disinfectant
Washington, D.C., December 9, 2025 – Preliminary results of a nationwide study suggest that the disinfectant used to treat water before it is distributed through pipes may impact the incidence of Legionnaire’s disease in certain parts of the country. The findings will be presented Dec. 9 at the annual meeting of the Society for Risk Analysis in Washington, D.C.
Waterborne ...
2025-12-09
FOR IMMEDIATE RELEASE
EMBARGOED UNTIL DECEMBER 9, 2025
Oyster Larvae on Drugs Move Slowly and Are Stressed
Study finds that exposure to addictive drugs like fentanyl and ketamine affect the behavior and survival rates of oyster larvae
Washington, D.C., December 9, 2025 – The discharge and prevalence of psychoactive drugs in surface waters has raised concerns about potential risks to ecosystems and public health. Yet there is limited information on the ecotoxicity of these compounds in marine environments and aquaculture.
A study presented on Dec. 9 at the annual meeting of the Society for Risk Analysis in ...
2025-12-09
PULLMAN, Wash. -- Washington State University researchers have discovered how a neural circuit – or a connection between two brain regions – drives relapse after opioid use, a finding that could lead to more effective treatments for opioid use disorders.
In a study published in the Journal of Neuroscience, researchers in the Department of Integrative Physiology and Neuroscience at WSU’s College of Veterinary Medicine used a preclinical model to model opioid use in humans and found that reducing the activity within a specific neuronal ...
2025-12-09
(ORLANDO, Dec. 9, 2025) Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific monoclonal antibody, and daratumumab, a CD38-directed monoclonal antibody, were 83% more likely to be alive without disease progression compared with those who received standard second-line therapies at a median of nearly 35 months of follow-up, according to the results of a new trial presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition.
The ...
2025-12-09
PHILADELPHIA – More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an autoimmune disorder that can cause life-threatening bleeding, were able to maintain safe platelet counts without serious bleeding episodes for at least one year. The results were published today in the New England Journal of Medicine, by researchers from the Perelman School of Medicine at the University of Pennsylvania, and presented by collaborators at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition Orlando, Florida (LBA-2).
ITP is an autoimmune condition where ...
LAST 30 PRESS RELEASES:
[Press-News.org] An assessment of the antidepressant potential of deramciclane in two animal tests
